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Photodynamic therapy (PDT) is a therapeutic modality used for
the treatment of a variety of solid neoplasms. The concept of PDT
is based on the selective uptake of a photosensitizing chemical in
tumour tissue followed by an irradiation of tumours with visible
light (Henderson and Dougherty, 1992). The treatment results in a
cascade of oxidative events causing cell death and eventual
tumour ablation (Pass, 1993).
There are numerous indications in the literature on the contribu-
tion of immune reactions to cancer cell inactivation during PDT
(Korbelik and Krosl, 1996; Dougherty et al, 1998). These reac-
tions rely on the activation in the early phase (during and immedi-
ately after light treatment) of non-specific immune effector cells,
such as monocytes/macrophages, neutrophils and mast cells
(Krosl et al, 1995). Tumouricidal activity of these activated
inflammatory cells, among which the macrophages receive a
particular attention, leads to the development of the tumour-
specific immunity on the later stages (Yamamoto et al, 1992b).
Increased macrophage activity after PDT in vitro and in vivo is
well documented. The enhancement of Fc-receptor-mediated
phagocytosis of macrophages exposed to the pg concentrations of
haematoporphyrin derivative or Photofrin and low light fluences
was reported by Yamamoto et al (1991). Same authors demon-
strated the enhanced ingestion activity of macrophages subjected
to small doses of cyanine dyes lumin and platonin and white
fluorescent light (Yamamoto et al, 1992a; Nakagawa et al, 1993).
Increased activity of peritoneal (Yamamoto et al, 1991) and
tumour-associated macrophages (Krosl et al, 1995) was also
reported after in vivo PDT.
Macrophages upon activation have been shown to produce
different cytotoxic species including proteases, reactive oxygen
intermediates, tumour necrosis factor alpha (TNF-a) and reactive
nitrogen species such as nitric oxide (NO) (Adams and Nathan,
1983; Albina and Reichner, 1998). PDT also results in a release of
different cytokines and oxidants from the macrophages and cells
in culture. For instance, peritoneal murine macrophages, when
sensitized by Photofrin II and exposed to light, may be stimulated
to produce TNF-a (Evans et al, 1990). The up-regulation of TNF-
a production in keratinocytes in vitro by PDT using a phthalo-
cyanine-derived photosensitizer has been reported (Anderson et al,
1993). Recently, NO production was demonstrated in phthalo-
cyanine-photosensitized tumour cells (Gupta et al, 1998). Both
TNF-a and NO have numerous physiological functions and,
besides direct tumouricidal action, they might affect tumour
microvasculature resulting in tumour regression (Asher et al,
1987; Korbelik et al, 1998).
Meta-tetra(hydroxyphenyl)chlorin (mTHPC, Foscan¤) is a
second generation photosensitizer that is currently being evaluated
for anti-neoplastic activity. Phase II/III clinical trials are in
progress for the treatment of patients with diffuse malignant
mesothelioma (Ris et al, 1991), primary head and neck squamous
cell carcinoma (Dilkes et al, 1997) and upper aerodigestive tract
cancers (Grosjean et al, 1993). The possibility for macrophage
activation upon photosensitization with mTHPC has not yet been
studied.
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Summary Photodynamic activation of macrophage-like cells contributes to an effective outcome of photodynamic therapy (PDT) treatment.
The possibility for an enhancement of macrophage activity by photosensitization with meta-tetra(hydroxyphenyl)chlorin (mTHPC) (1 mg ml–1)
was studied in U937, monocyte cell line differentiated into macrophages (U937F cells). Phagocytic activity of U937F cells was evaluated by
flow-cytometry monitoring of ingestion of fluorescein-labelled Escherichia coli particles. Increase in irradiation fluence up to 3.45 mJ cm–2
(corresponding irradiation time 15 s) resulted in significant increase in fluorescence signal (145%), while at higher light fluences the signal
lowered down to the untreated control values. A light energy-dependent production of tumour necrosis factor-alpha (TNF-a) by
photosensitized macrophages was further demonstrated using the L929 assay. The maximum TNF-a mediated cytolysis was observed at
28 mJ cm–2 and was 1.7-fold greater than that in control. In addition, we demonstrated a fluence-dependent increase in nitric oxide (NO)
production by mTHPC-photosensitized macrophages. NO release increased gradually and reached a plateau after irradiation fluence of
6.9 mJ cm–2. Cytotoxicity measurements indicated that the observed manifestations of mTHPC-photosensitized macrophage activation took
place under the sublethal light doses. The relevance of the present findings to clinical mTHPC-PDT is discussed.
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work the effect of mTHPC photosensitization on the phagocytic
capacity, TNF-a production and NO release by the macrophages.
The experimental model used was U937 human monocyte cell
line, induced to differentiate into macrophages.
MATERIALS AND METHODS
Photosensitizer
mTHPC (Foscan¤) was kindly provided by Scotia Pharmaceuticals
Ltd (Guildford, UK). Stock solution was made according to
manufacturer￿s recommendation (30% polyethylene glycol 400,
20% ethanol and 50% water). Further dilution was performed in
phosphate-buffered saline (PBS; Dutscher, Brumath, France) with
the addition of 2% heat-inactivated fetal calf serum (FCS; Dutscher,
France). Final mTHPC concentration was 1 mg ml—1.
Cell cultures
Mouse fibroblast L929 cells and human histocytic lymphoma U937
cells (European Collection of Cell Cultures, UK) were cultured in
RPMI-1640 medium (Gibco, France), supplemented with 10%
heat-inactivated FCS, 1% streptomycin—penicillin (Gibco, France)
and 200 mM L-glutamin (Gibco, France).
L929 cells growing in confluent cultures were trypsinized to
obtain cell suspension. Two hundred microlitres of cell suspension
containing 2 ´ 104 viable cells were plated per well into 96-well
microtitre dishes. Cells were allowed to attach to the dishes for
12 h at 37°C before being used in the TNF-a assay.
The differentiation of U937 cells into the macrophages (U937F
cells) was induced by 12-O-tetradecanoylphorbol-13-acetate (TPA;
Sigma), using the modification of an earlier described procedure
(Hoff, 1992). U937 cells were placed into the individual wells of the
24-well plates at a seeding density of 2 ´ 105 cells ml—1. TPA was
added into each well from an ethanol stock solution to reach the final
concentration of 100 ng ml—1 (final ethanol concentration was 1%).
Cells were incubated for 48 h at 37°C before being used in the exper-
iments. Majority of the cells attached to the plate￿s bottom in 24 h.
For the cytotoxicity assay, suspension of U937 cells in growth
medium was transferred into 50 ml polypropylene tube. TPA was
added to reach a final concentration of 100 ng ml—1. After that,
200 ml of cell suspension (2 ´ 105 cells ml—1) were plated per well
into 96-well microtitre dishes. Incubation conditions were the
same as described above.
PDT of U937F cells
Following 48 h incubation, cells were washed three times with PBS
and exposed to mTHPC (1 mg ml—1). After 3 h incubation at 37°C,
medium was removed, cells were washed three times with cold
PBS and fresh medium was added before cell irradiation.
Irradiation was carried out at 650 nm using a dye laser (Spectra-
Physics 375 B), pumped with an argon laser (Spectra-Physics 2020,
Les Ulis, France). The output power was 30 mW. Light spot was
13 cm in diameter, providing the fluence rate of 0.23 mW cm—2.
Phagocytosis assay
Rapid microfluorometric phagocytosis assay by using fluorescein-
conjugated E. coli particles was proposed earlier by Wan et al
(1993). We have modified the procedure with the aim of optimiza-
tion for flow cytometry measurements. Briefly, after light expo-
sure U937F cells were incubated with 30 ml of fluorescein
isothiocyanate (FITC), fluorescent E. coli particle suspension
(Vybrant “ Phagocytosis assay kit, Molecular Probes, Inc., USA),
for 1 h at 37°C. E. coli suspension was removed from the plate
wells and the extracellular fluorescence was quenched by 1 min
contact with 100 ml of trypan blue solution (Vybrant“
Phagocytosis assay kit, Molecular Probes, Inc., USA). The trypan
blue solution was aspirated and replaced by 100 ml of PBS. Cells
were removed from the dish by means of scraping. The intracel-
lular E. coli fluorescence was measured by flow cytometry tech-
nique. The flow cytometer (Orthocyte, OrthoDiagnostic Systems,
Roissy, France) was equipped with a xenon lamp and a filter block
for excitation at 488 nm. Fluorescence of FITC was collected
through a 530 ± 15 nm-band pass filter. Results were expressed as
the relative intracellular fluorescence, which was defined as the
ratio of FITC fluorescence intensity in experimental samples to
FITC fluorescence intensity in control cultures.
Photocytotoxicity assay
U937F cells plated in 96-well dishes were treated photodynami-
cally and were incubated for 18 h at 37°C. Cell survival was
assessed by 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyl-2H-tetra-
zolium bromide (MTT; Sigma) colourimetric assay, which
provides data equivalent to clonogenic assay (McHale et al, 1988;
Merlin et al, 1992). Briefly, 50 ml of 0.5% MTT solution were
added into each well and incubated for 3 h at 37°C to allow MTT
metabolization. After incubation, formazan crystals were
dissolved by adding 50 ml of 25% sodium dodecyl sulphate (SDS)
solution per well and vigorously pipetted to ensure homogeneity
of solution prior to scanning. The absorbance at 540 nm was
measured on a Multiskan MCC 340 plate reader (Flow).
Appropriate blanks were subtracted from experimental results.
The results were given as the percentage of the values obtained
with the control cultures.
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Figure 1 Phagocytic activity of U937F cells exposed to mTHPC (1 mg ml–1)
and red light (650 nm, 0.23 mW cm–2) as a function of irradiation fluence.
Phagocytic activity is expressed as a fluorescence intensity of ingested FITC-
labelled E. coli particles as assessed by flow cytometry (l em. = 530 nm)
immediately after PDT. Each value is the mean of five experiments ± s.e.m.
(bars); * P < 0.05 when compared with untreated controlNitrite determination
To assess the production of NO by U937F cells, the concentration
of nitrite in the culture medium from both the untreated or photo-
dynamically treated cells was measured using the Griess reaction,
as described earlier (Sveinbjornsson et al, 1996). Eighteen hours
after irradiation, 100 ml of supernatant from U937 cells were incu-
bated at 23°C with 50 ml of Griess reagent (1% sulphanilamide,
0.1%  N-(1-naphthyl)ethylenediamine dihydrochloride in 2.5%
H3PO4; all obtained from Sigma). After 10 min, absorbance at
550 nm was measured using a Multiskan plate reader. The same
experimental conditions (seeding density of 2 ´ 105 cells ml—1, time
intervals) have been applied to untreated control cells (neither
photosensitizer nor light). Nitrite concentration was determined
by comparing the absorbance with that of standard solutions of
sodium nitrite (NaNO2) in RPMI. The results were expressed in
percentages of nitrite production in experimental samples
compared to that of the untreated control cultures.
TNF-a-mediated cytolytic activity
Measurement of the bioactivity of TNF-a was based on moni-
toring the cytolytic effect of U937F cell supernatants on the TNF-
a responsive cell line, L929 (Evans et al, 1990). The U937F cells
were treated photodynamically and incubated for 18 h at 37°C.
After the incubation, 50 ml of cell supernatant was added to the
L929 cells growing in monolayers in sextuplates. Fifty microlitres
of a 2 mg ml—1 actinomycin D solution (Merck Sharp and Dohme
International, USA) was added to each well. In every experiment
(untreated cells, cells exposed to photosensitizer alone and photo-
dynamically treated cells) the solution of 1 mg ml—1 purified mouse
anti-human TNF-a monoclonal antibodies (Pharmingen, USA)
was then added to three of the sextuplates to neutralize TNF-a
activity. In addition, six wells containing L929 cells received
100 ml of complete medium containing actinomycin D only and
served as a control for cell viability in the absence of macrophage
supernatant. The plates were incubated for 18 h at 37°C. Cells
were then fixed in methanol:acetic acid (3:1) and stained by means
of 15-min incubation with 10% ethanol containing 0.5% crystal
violet. Plates were washed three times with water and were
allowed to dry. The remaining dye was solubilized with 100 ml of a
10% acetic acid and 20% ethanol solution. Plates were shaked
slowly and the absorbance of each well was measured at 540 nm
with Multiskan microplate reader.
Cytotoxicity was expressed as the absorbance values in experi-
mental wells relative to those in controls measured in the absence
of macrophage supernatant. To establish the specificity of the
TNF-a-induced cytolysis, the values of cytotoxicity detected in
the presence of TNF-a monoclonal antibodies were subtracted
from those obtained in their absence. Final results were expressed
as relative cytotoxicity, which was defined as the ratio of TNF-a-
mediated cytotoxicity in photodynamically treated samples to
TNF-a-mediated cytotoxicity in samples exposed to culture
medium from untreated macrophages (neither photosensitizer nor
light).
Statistical analysis
The results were expressed as mean ± standard error of the mean
(s.e.m.). For the phagocytosis, NO production and TNF-a assays,
the comparisons was also made using Mann—Whitney U-test.
Difference was considered significant when P-value was < 0.05.
RESULTS
Phagocytic activity of U937F cells after mTHPC
photosensitization
mTHPC loaded U937F cells were exposed to increasing doses of
light (l = 650 nm) and brought into contact for 1 h with fluores-
cein-labelled E. coli particles. Macrophage ingestion (phagocytic)
activity was then assayed with a flow cytometry technique by
taking advantage of the fluorescent properties of bioparticles
(lem. = 530 nm). Phagocytic activity of cells in the presence of
photosensitizer alone did not differ significantly from control
values (cells exposed to medium alone) (P > 0.05). Exposure of
macrophages to light affected their phagocytic activity in a dose-
dependent manner. The fluorescence of ingested bioparticles
began to increase after irradiation with the light fluence of
2.3 mJ cm—2 (corresponding irradiation time 10 s) and reached a
maximum (145%) at 3.45 mJ cm—2 (Figure 1). At light fluences up
to 14 mJ cm—2, phagocytic capacity was significantly higher than in
untreated control. Further increase in irradiation fluence led to
gradual decrease in phagocytosis. Light fluences greater than
28 mJ cm—2 resulted in phagocytosis suppression below the level
of untreated control.
Photocytotoxicity of U937F cells
To address the question if suppression of ingestion activity of the
macrophages was caused by cytotoxicity, a MTT assay was used
for photocytotoxicity measurements. Up to irradiation with the
fluence of 0.2 J cm—2 no significant cytotoxicity was observed as
compared to untreated control (Figure 2). Further increase in irra-
diation fluence resulted in a progressive decrease in cell survival
that reached 82% at 0.35 J cm—2 (Figure 2). Therefore, the suppres-
sion of phagocytic activity at irradiation fluence of 14 mJ cm—2 and
above cannot be explained by the irreversible cell photodamage,
but may be due to the sublethal cell injury.
mTHPC photosensitized macrophage activation 39
British Journal of Cancer (1999) 81(1), 37–42 © 1999 Cancer Research Campaign
100
75
50
25
0 1 10 100 1000
S
u
r
v
i
v
a
l
(
%
 
o
f
 
c
o
n
t
r
o
l
)
Irradiation fluence (mJ cm–2)
Figure 2 Photocytotoxicity of U937F cells exposed to mTHPC (1 mg ml–1)
and red light (650 nm, 0.23 mW cm–2) as a function of irradiation fluence.
Cytotoxicity was determined using MTT colorimetric assay 18 h following
PDT. Each value is a mean of three experiments ± s.e.m. (bars)Induction of TNF-a-mediated cytolysis by
photodynamically treated U937F cells
In this section we investigated the possibility for TNF-a produc-
tion by mTHPC-photosensitized U937F cells. Bioactivity of
TNF-a was measured monitoring the cytolytic effect of super-
natants collected from U937F cells at 18 h after exposure to
photosensitizer and light on the actinomycin D-sensitized L929
mouse fibroblast cell. L929 is a known TNF-a responsive cell line
and is commonly used for the testing of biological activity of
TNF-a. The data reported in the present section are for anti-TNF-
a preventable cytolysis (see Materials and Methods).
The TNF-a-mediated toxicity on L929 cells exposed to the
conditioned media from untreated macrophages was 20% (± 11%).
Increased level of toxicity induced by the supernatant from
untreated macrophages was expected since the U937 cells were
differentiated into macrophages by TPA, which induces TNF-a
production (Aderka et al, 1989). Toxicity in the presence of super-
natants from macrophages treated with sensitizer alone did not
differ significantly from that of controls.
As shown in Figure 3, conditioned media from photodynami-
cally treated U937F cells induced cytolytic effect on L929 fibro-
blast cells. L929 cytolysis increased significantly after exposure to
2.3 mJ cm—2. Maximum increase in cell cytolysis was observed
after irradiation with 27.6 mJ cm—2 and was 1.7-fold greater than in
control (Figure 3). Afterwards cytolysis decreased progressively,
reaching the baseline level after irradiation with the light fluence
0.2 J cm—2. It should be noted that the level of PDT-generated TNF-
a-independent component of L929 cell lysis was variable, but it
did not differ significantly from that induced by culture medium
from untreated macrophages.
NO production by photodynamically treated U937F
cells
In the present section we have studied NO generation from
mTHPC-photosensitized macrophages. NO production was tested
in macrophage supernatants 18 h after treatment by the conven-
tional colourimetric assay.
Additional parallel set of control cultures consisted of untreated
macrophages (neither photosensitizer nor light), tested under the
same experimental conditions. The level of NO production by the
untreated macrophages was 1.0 ± 0.2 mM and did not differ signif-
icantly from NO level released by macrophages exposed to photo-
sensitizer alone. When cells were treated photodynamically, the
level of NO in the macrophage supernatants increased gradually
with an increase in light fluences (Figure 4), reaching a maximum
(180%) after irradiation at 69 mJ cm—2. Further increase in irradia-
tion fluence caused the decrease in NO production, which still
remained significantly higher than that in the untreated controls.
Results in Figure 4 are expressed as the absorbance of photo-
dynamically treated samples relative to the absorbance of the
control culture exposed to photosensitizer alone.
DISCUSSION
Photodynamic activation of macrophage-like cells contributes to
an effective outcome of PDT treatment. Activated by photo-
dynamic treatment macrophages become more efficiently
involved in killing cancerous cells, as well as in phagocytosis of
tumour cell debris (Dougherty, 1998). The ingestion of PDT-
damaged or killed cells by macrophages may create conditions for
the tumour antigen presentation by these cells, resulting in a
possible development of tumour-specific immunity (Korbelik and
Krosl, 1996). Consequently, PDT appears to be highly receptive to
the adjuvant treatment with the macrophage-activating factors. For
example, the effect of PDT treatment of tumours was shown to be
enhanced by vitamin D3-binding protein-derived macrophage-
activating factor (DBMAF) (Korbelik et al, 1997), glucan SPG
(Krosl and Korbelik, 1994) as well as granulocyte—macrophage
colony-stimulating factor (GM-CSF) (Krosl et al, 1996).
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Figure 3 Biological activity of TNF-a produced by mTHPC-photosensitized
U937F cells (1 mg ml–1; 650 nm, 0.23 mW cm–2) as a function of irradiation
fluence. The bioactivity of TNF-a was determined based on the cytolytic
effects of macrophage supernatants on TNF-a-sensitive murine L929 cells.
The number of viable cells was determined by crystal violet colourimetric
assay 18 h after PDT. Cytolysis in the presence of the supernatants from
untreated macrophages was taken as unity. Each value is the mean of three
experiments ± s.e.m. (bars); * P < 0.05 when compared with untreated control
Figure 4 Nitrite production by U937F cells exposed to mTHPC (1 mg ml–1)
and red light (650 nm, 0.23 mW cm–2) as a function of irradiation fluence. The
percentage of nitrite in the medium was measured 18 h after PDT. The nitrite
level was expressed as percentage of the amount of nitrite produced in
untreated cells. Each value is the mean of five experiments ± s.e.m. (bars);
* P < 0.05 when compared with the controlPhotodynamic enhancement of macrophage phagocytosis has
been reported for HpD (Yamamoto et al, 1991), Photofrin II
(Yamamoto et al, 1994) and some cyanine dyes (Yamamoto et al,
1992a; Nakagawa et al, 1993). The results of the present study add
to this list mTHPC, a potent second-generation photosensitizer.
We have demonstrated that mTHPC and sublethal light doses
enhance macrophage phagocytic capacity (Figure 1). In the above
cited works, photodynamic activation of macrophage phagocytic
capacity was studied in the model of Fc-receptor-mediated phago-
cytosis of the opsonized erythrocytes (Yamamoto et al, 1991,
1994). The enhanced macrophage activity was considered to be
caused by lipid photoperoxidation reactions in co-present non-
adherent lymphocytes with the subsequent release of macrophage-
stimulating factors. In the present work, phagocytic activity of
U937F cells was studied in the model of macrophages interaction
with fluorescein conjugated E. coli particles. In this case phagocy-
tosis proceeds via mannose-fucose receptors on the ingesting cells.
Basically, these receptors recognize terminal mannose or fucose
saccharides on the lipopolysaccharide of invading bacteria
(Brown, 1995). Therefore, photosensitized by mTHPC enhance-
ment of ingestion capacity may be mediated by activation of
mannose-fucose receptors of U937F cells. The mechanism for
such photodynamic induction of receptor activation is presently
unclear. However, enhancement in phagocytic capacity can be
induced by cytokines released from the photosensitized
macrophages. For example, such cytokines as interferon (IFN)-g,
interleukin (IL)-4 and TNF-a are known to activate numerous
macrophage functions (Collins and Bancroft, 1992). Indeed, the
fact that under our experimental conditions mTHPC-photosensi-
tized macrophages can produce TNF-a was demonstrated by our
further experiments. As it is shown in Figure 3, light energy-
dependent induction of TNF-a-mediated cytolysis by photo-
dynamically treated macrophages was observed 18 h after
irradiation. The initial increase in TNF-a-mediated cytolysis was
taking place in the same range of light doses with phagocytosis
activation. It is therefore possible that TNF-a production
contributes to phagocytosis enhancement after mTHPC-PDT treat-
ment of the macrophages. TNF-a-mediated cytolysis decreased
after irradiation with the light fluences greater than 28 mJ cm—2 and
reached the untreated control level at 0.2 J cm—2. Photocytotoxicity
test employed under the same experimental conditions revealed
increase in toxicity after much higher irradiation fluences (ca. 20%
at 0.35 J cm—2) (Figure 2). Such correlation is consistent with an
earlier observation made by Evans et al (1990), who have demon-
strated that macrophages become incapable of producing TNF
before they are irreversibly damaged.
The relevance of these findings to clinical mTHPC-PDT
remains to be clarified. However, we would expect that increase in
phagocytosis could improve the PDT curative effect through the
cancer cell elimination by activated macrophages. Biological
significance of the TNF-a production after in vivo mTHPC-PDT
may be of particular interest, since TNFs are not only associated
with direct cytotoxicity on tumour cells, but also may mediate
tumour regression through the effects on the microvasculature
(Evans et al, 1990).
The important finding of our study is a fluence-dependent
increase in NO release from the macrophages photosensitized with
mTHPC and sublethal light doses (Figure 4). Compared to
phagocytosis enhancement, where the highest fluence applied
(0.2 J cm—2) resulted in phagocytosis suppression below the base
level, the NO release from photodynamically treated macrophages
was still greater as compared to the untreated control. The
increased level of NO production even at high irradiation fluences
may probably explain phagocytosis suppression. Indeed, NO
production was reported to exert significant negative effect on the
phagocytic function on rat elicited macrophages (Albina and
Reichner, 1998).
Finally, the relationship between phagocytosis activation,
release of NO and cytokines production may be established by
monitoring the macrophage phagocytic capacity in the presence of
NO synthase inhibitors and TNF-a antibodies, and this serves as
the source of ongoing investigations.
The implications of NO in the events participating in anti-
tumour effects of PDT are now well-established (Korbelik et al,
1998). NO has been proposed to be the key molecule determining
sensitivity to oxidative stress, including that induced by PDT, at
the level of the vascular endothelium in tumours (Parkins et al,
1995; Korbelik et al, 1998). Nevertheless, only few studies report
about PDT-induced NO production (Buettner and Kelley, 1997;
Gupta et al, 1998). The NO generation by human carcinoma cells
as a result of photosensitization with silicon-phtalocyanine was
recently reported (Gupta et al, 1998). The authors proposed that
NO might be involved in PDT-induced apoptosis (Gupta et al,
1998). Also, an increase in nitrosylhaemoglobin (¥ HO-NO)
production in tumour tissue of mice after Photofrin-PDT was
observed (Buettner and Kelley, 1997). The results of the present
work demonstrated for the first time the generation of NO by
photodynamically treated macrophages.
In our institution, mTHPC is being applied only for the treat-
ment of early-stage (in situ and microinvasive) malignancies of the
upper aerodigestive tract. Macrophages represent a large cell
population in the early-stage tumours (Korbelik and Krosl, 1996).
They are concentrated in lesion periphery and will, in all proba-
bility, be subjected to feeble irradiation fluences in course of PDT.
Therefore, reported in the present work manifestations of activa-
tion of macrophage-like cells by mTHPC and subcurative light
doses, are very likely to occur in clinical context.
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